These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37045678)

  • 1. The effect of neonatal vaccination for bovine respiratory disease in the face of a dual challenge with bovine viral diarrhea virus and Mannheimia hemolytica.
    Perkins-Oines S; Dias N; Krafsur G; Abdelsalam K; Perry G; Ensley D; Jones C; Chase CCL
    Vaccine; 2023 May; 41(19):3080-3091. PubMed ID: 37045678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and microbiological effects in high-risk beef calves administered intranasal or parenteral modified-live virus vaccines.
    Powledge SA; McAtee TB; Woolums AR; Robin Falkner T; Groves JT; Thoresen M; Valeris-Chacin R; Richeson JT
    J Anim Sci; 2022 Nov; 100(11):. PubMed ID: 35926833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternally derived humoral immunity to bovine viral diarrhea virus (BVDV) 1a, BVDV1b, BVDV2, bovine herpesvirus-1, parainfluenza-3 virus bovine respiratory syncytial virus, Mannheimia haemolytica and Pasteurella multocida in beef calves, antibody decline by half-life studies and effect on response to vaccination.
    Fulton RW; Briggs RE; Payton ME; Confer AW; Saliki JT; Ridpath JF; Burge LJ; Duff GC
    Vaccine; 2004 Jan; 22(5-6):643-9. PubMed ID: 14741155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
    Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
    Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of immunity of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV, and BRSV in experimentally infected calves.
    Peters AR; Thevasagayam SJ; Wiseman A; Salt JS
    Prev Vet Med; 2004 Dec; 66(1-4):63-77. PubMed ID: 15579335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of injectable trace minerals on humoral and cell-mediated immune responses to Bovine viral diarrhea virus, Bovine herpes virus 1 and Bovine respiratory syncytial virus following administration of a modified-live virus vaccine in dairy calves.
    Palomares RA; Hurley DJ; Bittar JH; Saliki JT; Woolums AR; Moliere F; Havenga LJ; Norton NA; Clifton SJ; Sigmund AB; Barber CE; Berger ML; Clark MJ; Fratto MA
    Vet Immunol Immunopathol; 2016 Oct; 178():88-98. PubMed ID: 27496747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of calves persistently infected with noncytopathic bovine viral diarrhea virus (BVDV) subtype 1b after vaccination with heterologous BVDV strains in modified live virus vaccines and Mannheimia haemolytica bacterin-toxoid.
    Fulton RW; Step DL; Ridpath JF; Saliki JT; Confer AW; Johnson BJ; Briggs RE; Hawley RV; Burge LJ; Payton ME
    Vaccine; 2003 Jun; 21(21-22):2980-5. PubMed ID: 12798641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of four commercially available multivalent modified-live virus vaccines against clinical disease, viremia, and viral shedding in early-weaned beef calves exposed simultaneously to cattle persistently infected with bovine viral diarrhea virus and cattle acutely infected with bovine herpesvirus 1.
    Chamorro MF; Walz PH; Passler T; Palomares R; Newcomer BW; Riddell KP; Gard J; Zhang Y; Galik P
    Am J Vet Res; 2016 Jan; 77(1):88-97. PubMed ID: 26709942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine viral diarrhea virus (BVDV) 1b: predominant BVDV subtype in calves with respiratory disease.
    Fulton RW; Ridpath JF; Saliki JT; Briggs RE; Confer AW; Burge LJ; Purdy CW; Loan RW; Duff GC; Payton ME
    Can J Vet Res; 2002 Jul; 66(3):181-90. PubMed ID: 12146890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
    Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
    Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission of bovine viral diarrhea virus 1b to susceptible and vaccinated calves by exposure to persistently infected calves.
    Fulton RW; Briggs RE; Ridpath JF; Saliki JT; Confer AW; Payton ME; Duff GC; Step DL; Walker DA
    Can J Vet Res; 2005 Jul; 69(3):161-9. PubMed ID: 16187545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical status and endoscopy of the upper respiratory tract of dairy calves infected with Bovine viral diarrhea virus 2 and Bovine herpes virus 1 after vaccination and trace minerals injection.
    Hoyos-Jaramillo A; Palomares RA; Bittar JH; Divers SJ; Chamorro MF; Berghaus R; Kirks SJ; Rush J; Edmondson M; Rodriguez A; Gonzalez-Altamiranda EA
    Res Vet Sci; 2022 Dec; 152():582-595. PubMed ID: 36201905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-bovine herpesvirus and anti-bovine viral diarrhea virus antibody responses in pregnant Holstein dairy cattle following administration of a multivalent killed virus vaccine.
    Smith BI; Rieger RH; Dickens CM; Schultz RD; Aceto H
    Am J Vet Res; 2015 Oct; 76(10):913-20. PubMed ID: 26413830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of antigen-specific T-cell subset activation to bovine respiratory disease viruses by a modified-live virus vaccine.
    Platt R; Burdett W; Roth JA
    Am J Vet Res; 2006 Jul; 67(7):1179-84. PubMed ID: 16817740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV and BRSV in experimentally infected calves.
    Salt JS; Thevasagayam SJ; Wiseman A; Peters AR
    Vet J; 2007 Nov; 174(3):616-26. PubMed ID: 17276108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus detection by PCR following vaccination of naive calves with intranasal or injectable multivalent modified-live viral vaccines.
    Walz PH; Newcomer BW; Riddell KP; Scruggs DW; Cortese VS
    J Vet Diagn Invest; 2017 Sep; 29(5):628-635. PubMed ID: 28545321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection.
    Kovács F; Magyar T; Rinehart C; Elbers K; Schlesinger K; Ohnesorge WC
    Vet Microbiol; 2003 Oct; 96(2):117-31. PubMed ID: 14519330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of injectable trace minerals administered concurrently with a modified live virus vaccine on long-term protection against bovine viral diarrhea virus acute infection in dairy calves.
    Bittar JHJ; Hoyos-Jaramillo A; Hurley DJ; Woolums AR; Havenga LJ; Lourenço JM; Barnett G; Gomes V; Saliki JT; Harmon DD; Palomares RA
    Res Vet Sci; 2018 Aug; 119():250-258. PubMed ID: 30036856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of protection against virulent bovine viral diarrhea virus type 2 in calves that had maternal antibodies and were vaccinated with a modified-live vaccine.
    Zimmerman AD; Boots RE; Valli JL; Chase CC
    J Am Vet Med Assoc; 2006 Jun; 228(11):1757-61. PubMed ID: 16740078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vaccination of pregnant beef heifers on the concentrations of serum IgG and specific antibodies to bovine herpesvirus 1, bovine viral diarrhea virus 1, and bovine viral diarrhea virus 2 in heifers and calves.
    Reppert EJ; Chamorro MF; Robinson L; Cernicchiaro N; Wick J; Weaber RL; Haines DM
    Can J Vet Res; 2019 Oct; 83(4):313-316. PubMed ID: 31571732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.